| Product Code: ETC8543213 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Monkeypox Vaccine and Treatment Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Monkeypox Vaccine and Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Monkeypox Vaccine and Treatment Market - Industry Life Cycle |
3.4 Netherlands Monkeypox Vaccine and Treatment Market - Porter's Five Forces |
3.5 Netherlands Monkeypox Vaccine and Treatment Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Netherlands Monkeypox Vaccine and Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Netherlands Monkeypox Vaccine and Treatment Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 Netherlands Monkeypox Vaccine and Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of monkeypox cases in the Netherlands |
4.2.2 Growing awareness about the importance of vaccination and treatment for monkeypox |
4.2.3 Government initiatives to promote vaccination programs |
4.3 Market Restraints |
4.3.1 Limited availability of monkeypox vaccines and treatments in the market |
4.3.2 High costs associated with the development and production of monkeypox vaccines and treatments |
5 Netherlands Monkeypox Vaccine and Treatment Market Trends |
6 Netherlands Monkeypox Vaccine and Treatment Market, By Types |
6.1 Netherlands Monkeypox Vaccine and Treatment Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Monkeypox Vaccine and Treatment Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Netherlands Monkeypox Vaccine and Treatment Market Revenues & Volume, By Vaccine, 2021- 2031F |
6.1.4 Netherlands Monkeypox Vaccine and Treatment Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.5 Netherlands Monkeypox Vaccine and Treatment Market Revenues & Volume, By Vaccinia Immune Globulin (VIG), 2021- 2031F |
6.2 Netherlands Monkeypox Vaccine and Treatment Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Monkeypox Vaccine and Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Netherlands Monkeypox Vaccine and Treatment Market Revenues & Volume, By Injectable, 2021- 2031F |
6.3 Netherlands Monkeypox Vaccine and Treatment Market, By End use |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Monkeypox Vaccine and Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Netherlands Monkeypox Vaccine and Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.4 Netherlands Monkeypox Vaccine and Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Netherlands Monkeypox Vaccine and Treatment Market Import-Export Trade Statistics |
7.1 Netherlands Monkeypox Vaccine and Treatment Market Export to Major Countries |
7.2 Netherlands Monkeypox Vaccine and Treatment Market Imports from Major Countries |
8 Netherlands Monkeypox Vaccine and Treatment Market Key Performance Indicators |
8.1 Number of reported monkeypox cases in the Netherlands |
8.2 Percentage of the population vaccinated against monkeypox |
8.3 Research and development investments in monkeypox vaccines and treatments |
8.4 Adoption rate of monkeypox vaccination programs by healthcare providers |
9 Netherlands Monkeypox Vaccine and Treatment Market - Opportunity Assessment |
9.1 Netherlands Monkeypox Vaccine and Treatment Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Netherlands Monkeypox Vaccine and Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Netherlands Monkeypox Vaccine and Treatment Market Opportunity Assessment, By End use, 2021 & 2031F |
10 Netherlands Monkeypox Vaccine and Treatment Market - Competitive Landscape |
10.1 Netherlands Monkeypox Vaccine and Treatment Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Monkeypox Vaccine and Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here